Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-12-13

Clinical Trial Update: Efficacy of Linaclotide in Patients With Overlapping Functional Gastrointestinal Disorders [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating the efficacy of linaclotide in patients with overlapping functional GI disorders (functional dyspepsia and constipation-predomin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Linaclotide (linaclotide)

Snippet

Sponsor: RenJi Hospital | Conditions: Functional Dyspepsia, Constipation-predominant Irritable Bowel Syndrome | Phase 4 | Status: UNKNOWN